Quarterly results
2018 Third quarter
We announced our 2018 third quarter results on Wednesday 31 October. Join the live webcast today with Emma Walmsley, CEO; Simon Dingemans, CFO; Luke Miels, President, Global Pharmaceuticals; and David Redfern, Chief Strategy Officer at 14:30 GMT, 10:30 EDT.
-
2011 Second Quarter - released 26 July 2011
Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our second quarter results 2011.
Key highlights
- Q2 reported sales -2%
- EPS before major restructuring* 25p
- Underlying sales growth of 5%
- Increased pipeline visibility and dividend of 16p, up 7%
-
2011 First Quarter - released 27 April 2011
Andrew Witty, CEO, discusses our first quarter results 2011.
Key highlights
- Reported sales -10%, underlying sales +4%
- EPS before major restructuring 32.2p (+9%), dividend 16p (+7%)
-
2010 Fourth Quarter - released 03 February 2011
Andrew Witty, CEO, discusses our fourth quarter results 2010.
Key highlights
- Long-term share buy-back programme initiated
- 2010 dividend up 7% to 65p
-
2010 Third Quarter - released 21 October 2010
Andrew Witty, CEO, discusses our third quarter results 2010
Key highlights
- Q3 EPS before major restructuring of 28.2p
- Q3 dividend up 7% to 16p
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
Product pipeline
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
